| Advent Home Health | |
| 700 E Silverado Ranch Blvd Ste 150, Las Vegas, Nevada 89183 | |
| (702) 260-4231 | |
| Name | Advent Home Health |
|---|---|
| Location | 700 E Silverado Ranch Blvd Ste 150, Las Vegas, Nevada |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 297155 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 89002, 89005, 89011, 89012, 89014, 89015, 89031, 89032, 89044, 89052, 89074, 89081, 89084, 89101, 89102, 89103, 89104, 89107, 89108, 89110, 89117, 89119, 89120, 89121, 89122, 89123, 89128, 89129, 89130, 89131, 89134, 89135, 89139, 89141, 89143, 89144, 89145, 89147, 89148, 89149, 89166, 89183 |
| NPI Number | 1689882557 |
| Organization Name | INTERMOUNTAIN MEDICAL HOLDINGS NEVADA INC |
| Doing Business As | INTERMOUNTAIN HEALTH HOME CARE |
| Address | 700 E Silverado Ranch Blvd, Suite 150, Las Vegas, NV 89183 |
| Phone Number | 702-260-4231 |
News Archive
According to Dame Sally Davies, Chief Medical Officer (CMO) for England, young children and some adults are not getting enough vitamin D. Not receiving enough of the vitamin can lead to health problems including rickets, broken bones, muscle weakness and infections including TB. Research last year suggested that a quarter of Britain's toddlers did not have enough vitamin D in their bloodstreams.
AMAG Pharmaceuticals, Inc. today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).
Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication alone.
InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).
› Verified 7 days ago
| Quality Rating: |
News Archive
According to Dame Sally Davies, Chief Medical Officer (CMO) for England, young children and some adults are not getting enough vitamin D. Not receiving enough of the vitamin can lead to health problems including rickets, broken bones, muscle weakness and infections including TB. Research last year suggested that a quarter of Britain's toddlers did not have enough vitamin D in their bloodstreams.
AMAG Pharmaceuticals, Inc. today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).
Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication alone.
InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 87.3 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 98.1 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 98.5 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 89.3 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 92.5 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.9 | 96.4 |
News Archive
According to Dame Sally Davies, Chief Medical Officer (CMO) for England, young children and some adults are not getting enough vitamin D. Not receiving enough of the vitamin can lead to health problems including rickets, broken bones, muscle weakness and infections including TB. Research last year suggested that a quarter of Britain's toddlers did not have enough vitamin D in their bloodstreams.
AMAG Pharmaceuticals, Inc. today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).
Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication alone.
InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 81.5 | 79.6 |
| How often patients got better at getting in and out of bed | 83 | 81.1 |
| How often patients got better at bathing | 89.1 | 82.3 |
| How often patients’ breathing improved | 86.9 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 87.4 | 75 |
| How often home health patients had to be admitted to the hospital | 13 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 15 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 88.8 | 94 |
News Archive
According to Dame Sally Davies, Chief Medical Officer (CMO) for England, young children and some adults are not getting enough vitamin D. Not receiving enough of the vitamin can lead to health problems including rickets, broken bones, muscle weakness and infections including TB. Research last year suggested that a quarter of Britain's toddlers did not have enough vitamin D in their bloodstreams.
AMAG Pharmaceuticals, Inc. today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).
Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication alone.
InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).
› Verified 7 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
According to Dame Sally Davies, Chief Medical Officer (CMO) for England, young children and some adults are not getting enough vitamin D. Not receiving enough of the vitamin can lead to health problems including rickets, broken bones, muscle weakness and infections including TB. Research last year suggested that a quarter of Britain's toddlers did not have enough vitamin D in their bloodstreams.
AMAG Pharmaceuticals, Inc. today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).
Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication alone.
InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).
› Verified 7 days ago
The patient survey data of Advent Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 92 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 85 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 88 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 82 | 78 |
News Archive
According to Dame Sally Davies, Chief Medical Officer (CMO) for England, young children and some adults are not getting enough vitamin D. Not receiving enough of the vitamin can lead to health problems including rickets, broken bones, muscle weakness and infections including TB. Research last year suggested that a quarter of Britain's toddlers did not have enough vitamin D in their bloodstreams.
AMAG Pharmaceuticals, Inc. today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).
Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication alone.
InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).
› Verified 7 days ago
Advisacare Solutions Of Nevada, Inc Location: 1840 E Warm Springs Rd Suite 100, Las Vegas, Nevada 89119 Ratings: Phone: (702) 896-6393 | |
Southwest Medical Associates Home Health Location: 8655 S Eastern Ave, Las Vegas, Nevada 89123 Ratings: Phone: (702) 383-0887 | |
In House Home Health Inc. Location: 3075 East Flamingo Road, Suite #116, Las Vegas, Nevada 89121 Ratings: Phone: (702) 894-9449 | |
Harmony Home Health Location: 820 Rancho Ln #20, Las Vegas, Nevada 89106 Ratings: Phone: (702) 880-7525 | |
Always Better Care Location: 6950 Via Olivero Ave Ste B4, Las Vegas, Nevada 89117 Ratings: Phone: (702) 364-8006 | |
Kindred At Home Location: 9121 West Russell Ste 118, Las Vegas, Nevada 89148 Ratings: Phone: (702) 228-0282 |